Skip to main content
Top
Published in: Archives of Virology 7/2009

01-07-2009 | Original Article

Influenza A virus matrix protein 1 interacts with hTFIIIC102-s, a short isoform of the polypeptide 3 subunit of human general transcription factor IIIC

Authors: Shengping Huang, Jingjing Chen, Huadong Wang, Bing Sun, Hanzhong Wang, Zhiping Zhang, Xianen Zhang, Ze Chen

Published in: Archives of Virology | Issue 7/2009

Login to get access

Abstract

Influenza A virus matrix protein 1 (M1) is a multifunctional protein that plays important roles during replication, assembly and budding of the virus. To search for intracellular protein components that interact with M1 protein and explore the potential roles of these interactions in the pathogenesis of influenza virus infection, 11 independent proteins, including hTFIIIC102-s protein, encoding a short isoform of the TFIIIC102 subunit of the human TFIIIC transcription factor, were screened from a human cell cDNA library using a yeast two-hybrid technique. The interaction between M1 protein and hTFIIIC102-s was studied in more detail. Mapping assays showed that the N-terminal globular region (amino acids 1–164) of the M1 protein and the five tandem tetratricopeptide repeats (TPR1-5, amino acids 149–362) in hTFIIIC102-s were necessary for the interaction. The interaction was confirmed by both glutathione-S-transferase (GST) pull-down assays and coimmunoprecipitation assays. In addition, coexpression of hTFIIIC102-s with M1 in HeLa cells inhibited the translocation of M1 into the nucleus. Taken together, the present data indicate that hTFIIIC102-s can interact with the structural M1 protein of the influenza virus, which provides a novel clue toward further understanding of the roles of M1 protein in the interactions between influenza virus and host cells.
Literature
1.
go back to reference Lamb RA, Lai CJ, Choppin PW (1981) Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci USA 78:4170–4174PubMedCrossRef Lamb RA, Lai CJ, Choppin PW (1981) Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci USA 78:4170–4174PubMedCrossRef
2.
go back to reference Yasuda J, Bucher DJ, Ishihama A (1994) Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimerical M gene. J Virol 68:8141–8146PubMed Yasuda J, Bucher DJ, Ishihama A (1994) Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimerical M gene. J Virol 68:8141–8146PubMed
3.
go back to reference Sha B, Luo M (1997) Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Boil 4:239–244CrossRef Sha B, Luo M (1997) Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Boil 4:239–244CrossRef
4.
go back to reference Arzt S, Baudin F, Barge A et al (2001) Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology 279:439–446PubMedCrossRef Arzt S, Baudin F, Barge A et al (2001) Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology 279:439–446PubMedCrossRef
5.
go back to reference Harris A, Forouhar F, Qiu S et al (2001) The crystal structure of the influenza matrix protein M1 at neutral pH: M1–M1 protein interfaces can rotate in the oligomeric structures of M1. Virology 289:34–44PubMedCrossRef Harris A, Forouhar F, Qiu S et al (2001) The crystal structure of the influenza matrix protein M1 at neutral pH: M1–M1 protein interfaces can rotate in the oligomeric structures of M1. Virology 289:34–44PubMedCrossRef
6.
go back to reference Shishkov AV, Goldanskii VI, Baratova LA et al (1999) The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci USA 96:7827–7830PubMedCrossRef Shishkov AV, Goldanskii VI, Baratova LA et al (1999) The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci USA 96:7827–7830PubMedCrossRef
7.
go back to reference Hui EK, Barman S, Tang DH et al (2006) YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42. J Virol 80:2291–2308PubMedCrossRef Hui EK, Barman S, Tang DH et al (2006) YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42. J Virol 80:2291–2308PubMedCrossRef
8.
go back to reference Zhirnov OP (1990) Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 176:274–279PubMedCrossRef Zhirnov OP (1990) Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 176:274–279PubMedCrossRef
9.
go back to reference Bui M, Whittaker G, Helenius A (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70:8391–8401PubMed Bui M, Whittaker G, Helenius A (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70:8391–8401PubMed
10.
go back to reference Hankins RW, Nagata K, Kato A (1990) Mechanism of influenza virus transcription inhibition by matrix (M1) protein. Res Virol 141:305–314PubMedCrossRef Hankins RW, Nagata K, Kato A (1990) Mechanism of influenza virus transcription inhibition by matrix (M1) protein. Res Virol 141:305–314PubMedCrossRef
11.
go back to reference Martin K, Helenius A (1991) Nuclear transport of influenza virus ribonucleoproteins: the Viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130PubMedCrossRef Martin K, Helenius A (1991) Nuclear transport of influenza virus ribonucleoproteins: the Viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130PubMedCrossRef
12.
go back to reference Kretzschmar E, Bui M, Rose JK (1996) Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 220:37–45PubMedCrossRef Kretzschmar E, Bui M, Rose JK (1996) Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 220:37–45PubMedCrossRef
13.
go back to reference Zhang J, Lamb RA (1996) Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 225:255–266PubMedCrossRef Zhang J, Lamb RA (1996) Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 225:255–266PubMedCrossRef
14.
go back to reference Gomez-Puertas P, Albo C, Perez-Pastrana E et al (2000) Influenza virus matrix protein is the major driving force in virus budding. J Virol 74:11538–11547PubMedCrossRef Gomez-Puertas P, Albo C, Perez-Pastrana E et al (2000) Influenza virus matrix protein is the major driving force in virus budding. J Virol 74:11538–11547PubMedCrossRef
15.
go back to reference Liu T, Ye Z (2005) Attenuating mutations of the matrix gene of influenza A/WSN/33 virus. J Virol 79:1918–1923PubMedCrossRef Liu T, Ye Z (2005) Attenuating mutations of the matrix gene of influenza A/WSN/33 virus. J Virol 79:1918–1923PubMedCrossRef
16.
go back to reference Hui EK, Smee DF, Wong MH et al (2006) Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection. J Virol 80:5697–5707PubMedCrossRef Hui EK, Smee DF, Wong MH et al (2006) Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection. J Virol 80:5697–5707PubMedCrossRef
17.
go back to reference Burleigh LM, Calder LJ, Skehel JJ et al (2005) Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol 79:1262–1270PubMedCrossRef Burleigh LM, Calder LJ, Skehel JJ et al (2005) Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol 79:1262–1270PubMedCrossRef
18.
go back to reference Reinhardt J, Wolff T (2002) The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet Microbiol 74:87–100CrossRef Reinhardt J, Wolff T (2002) The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet Microbiol 74:87–100CrossRef
19.
go back to reference Sato Y, Yoshioka K, Suzuki C et al (2003) Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology 310:29–40PubMedCrossRef Sato Y, Yoshioka K, Suzuki C et al (2003) Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology 310:29–40PubMedCrossRef
20.
go back to reference Bui M, Whittaker G, Helenius A (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70:8391–8401PubMed Bui M, Whittaker G, Helenius A (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70:8391–8401PubMed
21.
go back to reference Zhan Y, Hegde R, Srinivasula SM et al (2002) Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC. Cell Death Differ 9:439–447PubMedCrossRef Zhan Y, Hegde R, Srinivasula SM et al (2002) Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC. Cell Death Differ 9:439–447PubMedCrossRef
22.
go back to reference Lee HJ, Pyo JO, Oh Y et al (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 9:1303–1310PubMedCrossRef Lee HJ, Pyo JO, Oh Y et al (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 9:1303–1310PubMedCrossRef
23.
go back to reference Weins A, Schlondorff JS, Nakamura F et al (2007) Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc Natl Acad Sci USA 104:16080–16085PubMedCrossRef Weins A, Schlondorff JS, Nakamura F et al (2007) Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc Natl Acad Sci USA 104:16080–16085PubMedCrossRef
24.
go back to reference Avalos RT, Yu Z, Nayak DP (1997) Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol 71:2947–2958PubMed Avalos RT, Yu Z, Nayak DP (1997) Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol 71:2947–2958PubMed
25.
go back to reference Kiledjian M, Wang X, Liebhaber SA (1995) Identification of two KH domain proteins in the alpha-globin mRNP stability complex. Embo J 14:4357–4364PubMed Kiledjian M, Wang X, Liebhaber SA (1995) Identification of two KH domain proteins in the alpha-globin mRNP stability complex. Embo J 14:4357–4364PubMed
26.
go back to reference Ruppert S, Wang EH, Tjian R (1993) Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation. Nature 362:175–179PubMedCrossRef Ruppert S, Wang EH, Tjian R (1993) Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation. Nature 362:175–179PubMedCrossRef
27.
go back to reference Blatch GL, Lassle M (1999) The tetratricopeptide repeat: a structural motif mediating protein–protein interactions. BioEssays 21:932–939PubMedCrossRef Blatch GL, Lassle M (1999) The tetratricopeptide repeat: a structural motif mediating protein–protein interactions. BioEssays 21:932–939PubMedCrossRef
28.
go back to reference Zhirnov OP, Ksenofontov AL, Kuzmina SG (2002) Interaction of influenza A virus M1 matrix protein with caspases. Biochemistry (Mosc) 67:534–539CrossRef Zhirnov OP, Ksenofontov AL, Kuzmina SG (2002) Interaction of influenza A virus M1 matrix protein with caspases. Biochemistry (Mosc) 67:534–539CrossRef
29.
go back to reference Martin DA, Siegel RM, Zheng L (1978) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem 273:4345–4349CrossRef Martin DA, Siegel RM, Zheng L (1978) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem 273:4345–4349CrossRef
30.
go back to reference Hsieh YJ, Wang Z, Kovelman R (1999) Cloning and characterization of two evolutionarily conserved subunits (TFIIIC102 and TFIIIC63) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III. Mol Cell Biol 19:4944–4952PubMed Hsieh YJ, Wang Z, Kovelman R (1999) Cloning and characterization of two evolutionarily conserved subunits (TFIIIC102 and TFIIIC63) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III. Mol Cell Biol 19:4944–4952PubMed
31.
go back to reference Geiduschek EP, Kassavetis GA (2001) The RNA polymerase III transcription apparatus. J Mol Biol 310:1–26PubMedCrossRef Geiduschek EP, Kassavetis GA (2001) The RNA polymerase III transcription apparatus. J Mol Biol 310:1–26PubMedCrossRef
32.
go back to reference Huang Y, Maraia RJ (2001) Comparison of the RNA polymerase III transcription machinery in Schizosaccharomyces pombe, Saccharomyces cerevisiae and human. Nucleic Acids Res 29:2675–2690PubMedCrossRef Huang Y, Maraia RJ (2001) Comparison of the RNA polymerase III transcription machinery in Schizosaccharomyces pombe, Saccharomyces cerevisiae and human. Nucleic Acids Res 29:2675–2690PubMedCrossRef
Metadata
Title
Influenza A virus matrix protein 1 interacts with hTFIIIC102-s, a short isoform of the polypeptide 3 subunit of human general transcription factor IIIC
Authors
Shengping Huang
Jingjing Chen
Huadong Wang
Bing Sun
Hanzhong Wang
Zhiping Zhang
Xianen Zhang
Ze Chen
Publication date
01-07-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0416-7

Other articles of this Issue 7/2009

Archives of Virology 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.